Enhanced macrophage activity in granulomatous lesions of immune mice challenged with Mycobacterium tuberculosis

Journal of Immunology

Volumn 176, Issue 8, 2006, Pages 4931-4939

  Ordway, Diane ^a   Harton, Marisa ^a   Henao Tamayo, Marcela ^a   Montoya, Rose ^a   Orme, Ian M ^a   Gonzalez Juarrero, Mercedes ^a  

^a Department of Environmental and Radiological Health Sciences   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; BCG VACCINE; CD11B ANTIGEN; CD40 ANTIGEN; CYTOKINE; DEC 205 ANTIGEN; GAMMA INTERFERON; GLYCOPROTEIN P 15095; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 12; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 1; UNCLASSIFIED DRUG;

ADOLESCENT; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; BACTERIAL COUNT; BACTERIAL GROWTH; BCG VACCINATION; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL COUNT; CELL MIGRATION; CHRONIC DISEASE; CONTROLLED STUDY; DENDRITIC CELL; DISEASE COURSE; FEMALE; FOAM CELL; GRANULOMATOUS INFLAMMATION; GROWTH INHIBITION; IMMUNE DEFICIENCY; IMMUNITY; IMMUNOREGULATION; LUNG ALVEOLUS MACROPHAGE; LUNG PARENCHYMA; LUNG TUBERCULOSIS; LYMPHOCYTE; MORPHOLOGY; MOUSE; MYCOBACTERIUM BOVIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROVOCATION TEST; T LYMPHOCYTE SUBPOPULATION;

EID: 33645795220     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.176.8.4931     Document Type: Article

References (52)

1. North, R. J., and Y.-J. Jung. 2004. Immunity to tuberculosis. Annu. Rev. Immunol. 22: 599-623.
2. Black, G. F., R. E. Weir, S. D. Chaguluka, D. Warndorff, A. C. Crampin, L. Mwaungulu, L. Sichali, S. Floyd, L. Bliss, E. Jarman, et al. 2003. γ Interferon responses induced by a panel of recombinant and purified mycobacterial antigens in healthy, non-Mycobacterium bovis BCG-vaccinated Malawian young adults. Clin. Diagn. Lab. Immunol. 10: 602-611.
3. Orme, I. M. 2006. Preclinical testing of new vaccines for tuberculosis: a comprehensive review. Vaccine 9: 13-19.
4. Fine, P. E. M., and E. Vynnycky. 1998. The effect of heterologous immunity upon the apparent efficacy of (e.g. BCG) vaccines. Vaccine 16: 1923-1928.
5. Fine, P. 2005. Stopping routine vaccination for tuberculosis in schools. BMJ 331: 647-648.
6. Girard, M. P., U. Fruth, and M.-P. Kieny. 2005. A review of vaccine research and development: tuberculosis. Vaccine 23: 5725-5731.
7. + T cells in tuberculosis. Am. J. Respir. Crit. Care Med. 166: 1116-1121.
8. Saunders, B. M., A. A. Frank, I. M. Orme, and A. M. Cooper. 2002. CD4 is required for the development of a protective granulomatous response to pulmonary tuberculosis. Cell. Immunol. 216: 65-72.
9. Cooper, A. M., J. Magram, J. Ferrante, and I. M. Orme. 1997. IL-12 is crucial to the development of protective immunity in mice intravenously infected with Mycobacterium tuberculosis. J. Exp. Med. 186: 39-46.
10. Flynn, J. L., M. M. Goldstein, K. J. Triebold, J. Sypek, S. Wolf, and B. R. Bloom. 1995. IL-12 increases resistance of BALB/c mice to Mycobacterium tuberculosis infection. J. Immunol. 155: 2515-2524.
11. Roach, D. R., A. G. D. Bean, C. Demangel, M. P. France, H. Briscoe, and W. J. Britton. 2002. TNF regulates chemokine induction essential for cell recruitment, granuloma formation, and clearance of mycobacterial infection. J. Immunol. 168: 4620-4627.
12. Orme, I., A. Roberts, J. Griffin, and J. Abrams. 1993. Cytokine secretion by CD4 T lymphocytes acquired in response to Mycobacterium tuberculosis infection. J. Immunol. 151: 518-525.
13. hiUPU population. Infect. Immun. 73: 7759-7764.
14. Kamath, A. B., and S. M. Behar. 2005. Anamnestic responses of mice following Mycobacterium tuberculosis infection. Infect. Immun. 73: 6110-6118.
15. Taylor, J. L., D. J. Ordway, J. Troudt, M. Gonzalez-Juarrero, R. J. Basaraba, and I. M. Orme. 2005. Factors associated with severe granulomatous pneumonia in Mycobacterium tuberculosis-infected mice vaccinated therapeutically with HSP65 DNA. Infect. Immun. 73: 5189-5193.
16. Taylor, J. L., O. C. Turner, R. J. Basaraba, J. T. Belisle, K. Huygen, and I. M. Orme. 2003. Pulmonary necrosis resulting from DNA vaccination against tuberculosis. Infect. Immun. 71: 2192-2198.
17. Basaraba, R. J., A. A. Izzo, L. Brandt, and I. M. Orme. 2006. Decreased survival of guinea pigs infected with Mycobacterium tuberculosis after multiple BCG vaccinations. Vaccine 24: 279-286.
18. Kita, Y., T. Tanaka, S. Yoshida, N. Ohara, Y. Kaneda, S. Kuwayama, Y. Muraki, N. Kanamaru, S. Hashimoto, and H. Takai. 2005. Novel recombinant BCG and DNA-vaccination against tuberculosis in a cynomolgus monkey model. Vaccine 23: 2132-2135.
19. Gonzalez-Juarrero, M., J. Turner, R. J. Basaraba, J. T. Belisle, and I. M. Orme. 2002. Florid pulmonary inflammatory responses in mice vaccinated with antigen-85 pulsed dendritic cells and challenged by aerosol with Mycobacterium tuberculosis. Cell. Immunol. 220: 13-19.
20. Jung, Y.-J., L. Ryan, R. LaCourse, and R. J. North. 2005. Properties and protective value of the secondary versus primary T helper type 1 response to airborne Mycobacterium tuberculosis infection in mice. J. Exp. Med. 201: 1915-1924.
21. Nolt, D., and F. L. Joanne. 2004. Interleukin-12 therapy reduces the number of immune cells and pathology in lungs of mice infected with Mycobacterium tuberculosis. Infect. Immun. 72: 2976-2988.
22. Cooper, A. M., J. Magram, J. Ferrante, and I. M. Orme. 1998. Mice lacking IL-12 p40 are more susceptible to aerosol infection with Mycobacterium tuberculosis than mice lacking IL-12 p35. In TB: Molecular Mechanisms and Immunologic Aspects. April 2-8, 1998. Keystone Symposia, Silverthorne, CO, pp. 14-16.
23. Cooper, A. M., A. D. Roberts, E. R. Rhoades, J. E. Callahan, D. M. Getzy, and I. M. Orme. 1995. The role of interleukin-12 in acquired immunity to Mycobacterium tuberculosis infection. Immunology 84: 423-432.
24. Caruso, A. M., N. Serbina, E. Klein, K. Triebold, B. R. Bloom, and J. L. Flynn. 1999. Mice deficient in CD4 T cells have only transiently diminished levels of IFN-γ, yet succumb to tuberculosis. J. Immunol. 162: 5407-5416.
25. Ehlers, S., J. Benini, H.-D. Held, C. Roeck, G. Alber, and S. Uhlig. 2001. αβ T cell receptor-positive cells and interferon-γ, but not inducible nitric oxide synthase, are critical for granuloma necrosis in a mouse model of mycobacteria-induced pulmonary immunopathology. J. Exp. Med. 194: 1847-1859.
26. Gonzalez-Juarrero, M., J. M. Hattle, A. Izzo, A. P. Junqueira-Kipnis, T. S. Shim, B. C. Trapnell, A. M. Cooper, and I. M. Orme. 2005. Disruption of granulocyte macrophage-colony stimulating factor production in the lungs severely affects the ability of mice to control Mycobacterium tuberculosis infection. J. Leukocyte Biol. 77: 914-922.
27. Turner, J., M. Gonzalez-Juarrero, D. L. Ellis, R. J. Basaraba, A. Kipnis, I. M. Orme, and A. M. Cooper. 2002. In vivo IL-10 production reactivates chronic pulmonary tuberculosis in C57BL/6 mice. J. Immunol. 169: 6343-6351.
28. Bodnar, K. A., N. V. Serbina, and J. L. Flynn. 2001. Fate of Mycobacterium tuberculosis within murine dendritic cells. Infect. Immun. 69: 800-809.
29. Tailleux, L., O. Neyrolles, S. Honore-Bouakline, E. Perret, F. Sanchez, J.-P. Abastado, P. H. Lagrange, J. C. Gluckman, M. Rosenzwajg, and J.-L. Herrmann. 2003. Constrained intracellular survival of Mycobacterium tuberculosis in human dendritic cells J. Immunol. 170: 1939-1948.
30. Junqueira-Kipnis, A. P., J. Turner, M. Gonzalez-Juarrero, O. C. Turner, and I. M. Orme. 2004. Stable T-cell population expressing an effector cell surface phenotype in the lungs of mice chronically infected with Mycobacterium tuberculosis. Infect. Immun. 72: 570-575.
31. Abebe, F., T. Mustafa, A. H. Nerland, and G. A. Bjune. 2006. Cytokine profile during latent and slowly progressive primary tuberculosis: a possible role for interleukin-15 in mediating clinical disease. Clin. Exp. Immunol. 143: 180-192.
32. Khader, S. A., J. E. Pearl, K. Sakamoto, L. Gilmartin, G. K. Bell, D. M. Jelley-Gibbs, N. Ghilardi, F. deSauvage, and A. M. Cooper. 2005. IL-23 compensates for the absence of IL-12p70 and is essential for the IL-17 response during tuberculosis but is dispensable for protection and antigen-specific IFN-γ responses if IL-12p70 is available. J. Immunol. 175: 788-795.
33. Gonzalez-Juarrero, M., T. S. Shim, A. Kipnis, A. P. Junqueira-Kipnis, and I. M. Orme. 2003. Dynamics of macrophage cell populations during murine pulmonary tuberculosis J. Immunol. 171: 3128-3135.
34. Ordway, D., M. Henao-Tamayo, I. M. Orme, and M. Gonzalez-Juarrero. 2005. Foamy macrophages within lung granulomas of mice infected with Mycobacterium tuberculosis express molecules characteristic of dendritic cells and antiapoptotic markers of the TNF receptor-associated factor family. J. Immunol. 175: 3873-3881.
35. Arch, R. H., R. W. Gedrich, and C. B. Thompson. 1998. Tumor necrosis factor receptor-associated factors (TRAFS): a family of adapter proteins that regulates life and death. Genes Dev. 12: 2821-2830.
36. Devergne, O., E. Hatzivassiliou, K. Izumi, K. Kaye, M. Kleijnen, E. Kieff, and G. Mosialos. 1996. Association of TRAF1, TRAF2, and TRAF3 with an Epstein-Barr virus lmp1 domain important for B-lymphocyte transformation: role in NF-κB activation. Mol. Cell. Biol. 16: 7098-7108.
37. Sandberg, M., W. Hammerschmidt, and B. Sugden. 1997. Characterization of lmp-1's association with TRAF1, TRAF2, and TRAF3. J. Virol. 71: 4649-4656.
38. Orme, I. M., D. N. McMurray, and J. T. Belisle. 2001. Tuberculosis vaccine development: recent progress. Trends Microbiol. 9: 115-118.
39. Orme, I. M. 2005. Mouse and guinea pig models for testing new tuberculosis vaccines. Tuberculosis 85: 13-17.
40. Orme, I. M. 1999. Beyond BCG: the potential for a more effective TB vaccine. Mol. Med. Today 5: 487-492.
41. Munz, C., R. M. Steinman, and S.-I. Fujii. 2005. Dendritic cell maturation by innate lymphocytes: coordinated stimulation of innate and adaptive immunity. J. Exp. Med. 202: 203-207.
42. Fulton, S. A., T. D. Martin, R. W. Redline, and W. Henry Boom. 2000. Pulmonary immune responses during primary Mycobacterium bovi's-Calmette-Guerin bacillus infection in C57BL/6 mice. Am. J. Respir. Cell Mol. Biol. 22: 333-343.
43. Flynn, J. L., and J. Chan. 2001. Immunology of tuberculosis. Annu. Rev. Immunol. 19: 93-129.
44. Turner, O. C., R. J. Basaraba, and I. M. Orme. 2003. Immunopathogenesis of pulmonary granulomas in the guinea pig after infection with Mycobacterium tuberculosis. Infect. Immun. 71: 864-871.
45. Dillon, S. M., J. F. Griffin, D. N. Hart, J. D. Watson, and M. A. Baird. 1998. A long-lasting interferon-γ; response is induced to a single inoculation of antigen-pulsed dendritic cells. Immunology 95: 132-140.
46. Demangel, C., U. Palendira, C. G. Feng, A. W. Heath, A. G. D. Bean, and W. J. Britton. 2001. Stimulation of dendritic cells via CD40 enhances immune responses to Mycobacterium tuberculosis infection. Infect. Immun. 69: 2456-2461.
47. Marino, S., S. Pawar, C. L. Fuller, T. A. Reinhart, J. L. Flynn, and D. E. Kirschner. 2004. Dendritic cell trafficking and antigen presentation in the human immune response to Mycobacterium tuberculosis. J. Immunol. 173: 494-506.
48. Demangel, C., P. Bertolino, and W. J. Britton. 2002. Autocrine 1L-10 impairs dendritic cell (DC)-derived immune responses to mycobacterial infection by suppressing DC trafficking to draining lymph nodes and local IL-12 production. Eur. J. Immunol. 32: 994-1002.
49. + T lymphocyte responses. J. Immunol. 172: 3725-3735.
50. Bonifaz, L. C., D. P. Bonnyay, A. Charalambous, D. I. Darguste, S.-I. Fujii, H. Soares, M. K. Brimnes, B. Moltedo, T. M. Moran, and R. M. Steinman. 2004. In vivo targeting of antigens to maturing dendritic cells via the DEC-205 receptor improves T cell vaccination. J. Exp. Med. 199: 815-824.
51. Demangel, C., A. G. D. Bean, A. Martin, C. G. Feng, A. T. Kamath, and W. J. Britton. 1999. Protection against aerosol Mycobacterium tuberculosis infection using Mycobacterium bovis bacillus Calmette Guerin-infected dendritic cells. Eur. J. Immunol. 29: 1972-1979.
52. Pym, A., P. Brodin, L. Majlessi, R. Brosch, C. Demangel, A. Williams, K. E. Griffiths, G. Marchal, C. Leclerc, and S. T. Cole. 2003. Recombinant BCG exporting ESAT-6 confers enhanced protection against tuberculosis. Nat. Med. 9: 533-539.